Loading the company…
Loading the company…
Families: Aneurysm & intracranial embolization.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Microport Neurotech Shanghai (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (2). The latest was on 2026-05-20.
| Family | Decisions on record |
|---|---|
| Aneurysm & intracranial embolization | 4 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-05-20 | 510(k) | K260351 | Numen Helia Coil Embolization System; NumenFR Detachment System |
| 2024-09-30 | 510(k) | K242154 | Numen Coil Embolization System; NumenFR Detachment System |
| 2024-01-10 | 510(k) | K232955 | Numen Coil Embolization System; NumenFR Detachment System |
| 2021-09-01 | 510(k) | K203625 | Numen Coil Embolization System; NumenFR Detachment System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Microport Neurotech Shanghai.